Concepedia
Statistics
Publications
35
Citations
1.6K
H-Index
23
Active since
1994
Affiliations
Lawrence Livermore National Laboratory(Current)
VA Northern California Health Care System
Lawrence Livermore National Security
University of California, Davis
University of California Davis Medical Center
Michael Malfatti is an author at Lawrence Livermore National Laboratory specializing in pharmacology, medicine, and oncology.
Publications per year
1994–2021
Predicting a Drug’s Membrane Permeability: A Computational Model Validated With <i>in Vitro</i> Permeability Assay Data
Brian J. Bennion, Nicholas A. Be, M. Windy McNerney et al. · The Journal of Physical Chemistry B · 2017 · 279 citations · Full text
Pharmacy, Biophysics, Pharmacology +17
Cancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and mice
Hong Cai, Edwina N. Scott, Abeer Othman A. Kholghi et al. · Science Translational Medicine · 2015 · 177 citations · Full text
Medicine, Oncology, Pharmacology +17
The identification of [2-14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans
Michael Malfatti, Kristen S. Kulp, Mark G. Knize et al. · Carcinogenesis · 1999 · 100 citations
Pharmacy, Pharmacokinetics, Pharmacology +15
Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses
Kenneth W. Turteltaub, Karen H. Dingley, Kellie D. Curtis et al. · Cancer Letters · 1999 · 92 citations
Medicine, Biochemistry, Pharmacology +7
N-Glucuronidation of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) and N-hydroxy-PhIP by specific human UDP-glucuronosyltransferases
Michael Malfatti, James S. Felton · Carcinogenesis · 2001 · 75 citations
Medicine, Biochemistry, Toxicology +11
1–5 of 35